BridgeMD
New treatment option for Central Visual Impairment
Official title Factors in Learning And Plasticity: Macular Degeneration
ClinicalTrials.gov ID: NCT05454124
What this study is testing
- What it's testing
- A greater understanding of plasticity after central vision loss can inform new therapies for treating low vision and has the potential to benefit millions of individuals suffering from low vision. The treatment of low vision is particularly relevant to the mission of the NEI to support research on visual disorders, mechanisms of visual function, and preservation of sight.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 89
You may be able to join if
- Aged 18-89
- Severely impaired vision in both eyes (20/100 or worse)
- diagnosis of Macular Degeneration by an Ophthalmologist
- Light sensitivity in the macular retina that is at least 10 dB units worse than in peripheral regions, as demonstrated by a scanning laser...
- Medical record review indicating this level of disease severity has been present for at least 2 years
You likely can't join if
- Pacemaker or any ferromagnetic metal implanted in their body
- Metal of any type implanted in their head (limited dental work is acceptable)
- Claustrophobia
- Being hearing-impaired
- Weight over 300 pounds
- Maximum body girth over 60 inches
See the full eligibility criteria
- Aged 18-89
- Severely impaired vision in both eyes (20/100 or worse)
- diagnosis of Macular Degeneration by an Ophthalmologist
- Light sensitivity in the macular retina that is at least 10 dB units worse than in peripheral regions, as demonstrated by a scanning laser ophthalmoscope (MAIA)
- Medical record review indicating this level of disease severity has been present for at least 2 years
- Reside within 50 miles of study site
- Pacemaker or any ferromagnetic metal implanted in their body
- Metal of any type implanted in their head (limited dental work is acceptable)
- Claustrophobia
- Being hearing-impaired
- Weight over 300 pounds
- Maximum body girth over 60 inches
- Previous serious head injury
- Presence of hallucinations or delusions
- Excessive old, or colorful tattoos, especially near the head
- Pregnancy
- Braces/permanent retainer
The study team makes the final eligibility decision.
Where it's taking place
- Birmingham, Alabama, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 89 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Birmingham, Alabama, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.